Clinicians surveyed for a new study discussed how unvalidated genomic results could affect healthcare workflows and patients.
Patients who've learned their genetic risk of disease worry about healthcare law changes in the US, Kaiser Health News reports.
According to ASHG, the final rules, issued this week, will significantly weaken patient privacy protections under ADA and GINA.
The companies are working together to help insurers reduce wasteful spending and spur use of medically necessary tests.
Patronus will use BaseHealth's platform to provide health assessments based on patients' genomics, medical histories, and environmental risk factors.
A medical genetics practice's lawsuit against a government insurance administrator points to continued uncertainty about reimbursement for NGS testing in Germany.
Recent cost analyses funded by Ariosa and Natera found that NIPT could replace conventional screening in the US and be cost-neutral if provided at certain prices.
OKP will pay for testing if standard first trimester screening indicates a risk higher than 1:1000 for trisomies 21, 18, or 13.
The collaborators will explore how InterSystems' HealthShare health informatics platform can support genomic and clinical data integration and analysis
BioEnterprise's Midwest Health Care Venture Investment Report showed a total 47 companies raising a combined $155.6 million during the first quarter of 2009, compared with 14 companies winning $133.5 million in the year-ago period.
The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.
Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.
In Science this week: in vitro generation of human reproductive cells, and more.
Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.